Clinical Trials
3 trialsNCT05213312 2022-06-15
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
Shanghai Zhongshan Hospital
Phase 2/3 Unknown
NCT03987815 2020-12-17
Neoadjuvant Nivolumab for Operable Esophageal Carcinoma
Samsung Medical Center
Phase 2 Unknown
NCT04503967 2020-08-07
OASIS
Shanghai Zhongshan Hospital
Phase 2 Unknown